HRMY · ISSUER CIK 1802665
Harmony Biosciences Holdings, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 1 Harmony Biosciences Holdings, Inc. insiders reported $0.00 of open-market purchases and $3.1M of sales on SEC Form 4.
↗1 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 2 of 2 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$3.1MInsider selling
−$3.1MNet open-market
Sep 18, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 18, 202616:48 | Sep 18, 2026from Sep 16, 2026 | HRMY | CHIEF MEDICAL OFFICER | S · Sell10b5-1 | $43.05 | −38,452 | 13,115 | -75% | −$1.7M | ||
| Sep 18, 202616:48 | Sep 18, 2026from Sep 16, 2026 | HRMY | CHIEF MEDICAL OFFICER | M · Exercise10b5-1 | $30.40 | +38,452 | 48,967 | +366% | $1.2M | ||
| Sep 9, 202617:12 | Sep 8, 2026from Sep 4, 2026 | HRMY | CHIEF MEDICAL OFFICER | S · Sell10b5-1 | $42.80 | −33,954 | 13,115 | -72% | −$1.5M | ||
| Sep 9, 202617:12 | Sep 8, 2026 | HRMY | CHIEF MEDICAL OFFICER | M · Exercise10b5-1 | $30.49 | +22,954 | 36,069 | +175% | $700K |